Risk Adjuster | Non-LIS Subjects |
LIS Subjects | |||
---|---|---|---|---|---|
MAPE | Adj R^2 |
MAPE | Adj R^2 |
||
Demographics | Age+gender | 620 | 0.0108 | 737 | 0.0084 |
RxHCC | RxHCC (score) | 520 | 0.2056 | 612 | 0.2438 |
Prior Drug | RxClass (48 indicators) | 406 | 0.4105 | 526 | 0.3833 |
Information | Cost (annualized) | 420 | 0.4776 | 478 | 0.5687 |
RxHCC+ Prior Drug |
RxHCC+RxClass (48 indicators) |
403 | 0.4173 | 516 | 0.4118 |
Use Info | RxHCC+Prior Cost (annualized) |
392 | 0.5225 | 451 | 0.6034 |
Source: Authors’ analysis
Notes: Includes all subjects with at least one month of enrollment in 2006. Cost (annualized) = 12*actual drug expenditure in 2006/months of enrollment in 2006. The MAPE (Mean Absolute Prediction Error) is the average of the absolute difference between the predicted and actual plan liability for each subject.